MedPath

Disulfiram for the treatment of crack dependence. A pilot study.

Phase 1
Conditions
crack cocaine addiction
Mental Health - Addiction
Registration Number
ACTRN12611000103965
Lead Sponsor
aboratorio de Estudos em Neurociencias Aplicadas (LENA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

crack dependence without other psychiatric disorder living in Palmas city capable of consenting not be in treatment for at least 60 days

Exclusion Criteria

cardiac moderate diseaase
pulmonary moderate disease
hepatic disease
renal disease
vascular diasease
epilepsy
severe malnutrition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath